This document is a publication of a new patent application (US20260085338A1) filed with the USPTO on September 6, 2023. The application describes a Pseudomonas sp. strain engineered for the production of recombinant proteins, specifically utilizing a nucleotide sequence encoding a phi15 RNA polymerase. It also covers plasmids designed for integration or replication within Pseudomonas sp., featuring a phi15 promoter linked to sequences for recombinant protein insertion or expression.

This patent application does not impose any immediate regulatory obligations on companies. However, it signifies potential future intellectual property developments in the biotechnology sector, particularly for entities involved in recombinant protein production. Companies operating in this space should monitor the patent's progress and consider its implications for their own research and development activities and potential licensing needs.